Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1Phase 2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Prostatic Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 254Cyclophosphamide 244Specimen Handling 196fludarabine 173Magnetic Resonance Spectroscopy 170Biopsy 145Nivolumab 124Carboplatin 99Radiotherapy 92Paclitaxel 90venetoclax 81Cisplatin 80fludarabine phosphate 79Gemcitabine 78Injections 69Ipilimumab 66Dexamethasone 63atezolizumab 58Cetuximab 57Bevacizumab 57Azacitidine 57Radiation 56Fluorouracil 56durvalumab 54Radiosurgery 51Temozolomide 48Oxaliplatin 44Rituximab 43Irinotecan 43Docetaxel 43

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Gene Expression Profiling × 1 year × Clear all
NCT00977457 2025-08-19

Genetic Testing in Predicting Biomarkers of Recurrence in Patients With Prostate Cancer Undergoing Surgery

City of Hope Medical Center

Phase 1 Active not recruiting
1,045 enrolled
Genitourinary

Prostatic Neoplasms

NCT00873275 2025-06-22

Ursodiol, Combination Chemotherapy, and Bevacizumab in Treating Patients With Stage IV Colorectal Cancer

City of Hope Medical Center

Phase 1 Completed
11 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡